therapies

October 15, 2026 10 min watch Add topic to email alerts Receive an email when new articles are posted on Please provide your email …

A new electronic implant system can help lab‑grown pancreatic cells mature and function properly, potentially providing a basis for novel, cell-based therapies for diabetes. The approach, developed by researchers at …

Breakthrough T1DSpotlight on OPF-310: A porcine-derived cell therapy in clinical trialsOne of our most promising avenues toward cures for type 1 diabetes is cell therapies. Learn more about one of …

Former Bristol Myers Squibb and Celgene executive to strengthen the Fund’s impact strategy and fuel transformative investments across innovative modalities BOSTON, Jan. 21, 2026 /PRNewswire/ — The T1D Fund: A Breakthrough …

NatureLab-made islet cell implants sail through diabetes trials, but are they ready yet?First-in-human studies provide hope that islet replacement therapies derived from stem cells will prove safe and effective in …

At the American Heart Association (AHA) 2025 Scientific Sessions in New Orleans, experts emphasized a paradigm shift toward holistic management of patients with type 2 diabetes (T2D) and chronic kidney …

Barchart.com Type 1 Diabetes Market Report 2032: Latest FDA, EMA, PDMA, Pipeline Therapies, EpidemiologyDelveInsight's “Type 1 Diabetes Market Insights, Epidemiology, Market Forecast – 2032” report provides a detailed understanding of …

Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis …

[00:00:00] Scott K. Johnson: I’m excited to introduce Stefany Shaheen, Chief Strategy Officer of Advanced Regenerative Manufacturing Institute, or ARMI. And BioFab USA, a program of ARMI. Stefany’s background is …